Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 25/03/04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 31/07/16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 02/05/21 |
Ryan Baker
IRC | Investor Relations Contact | - | 30/04/23 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 24/07/23 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 31/10/16 |
Mike Smith
PRN | Corporate Officer/Principal | - | 31/01/16 |
Rachel Morten
LAW | General Counsel | - | 31/12/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 31/01/19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 31/07/16 |
Albert Cha
BRD | Director/Board Member | 51 | 31/12/15 |
Edward Unkart
BRD | Director/Board Member | 74 | 30/11/14 |
Nancy Stuart
BRD | Director/Board Member | 65 | 17/03/21 |
Patrick Treanor
BRD | Director/Board Member | - | 25/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,188,296 | 41,670,541 ( 98.77 %) | 0 | 98.77 % |
Company contact information
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comSector
1st Jan change | Capi. | |
---|---|---|
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
-49.84% | 10.12B | |
+5.24% | 9.06B |